Prostate Cancer Screening, Detection Both Down in US

Prostate Cancer Screening, Detection Both Down in US

(HealthDay News) -- Fewer US men are being screened for prostate cancer, and fewer cases of the disease are being diagnosed nationwide. These findings, published in the Journal...

 Novel PSA Assay Improves Prostate Cancer Diagnosis

Novel PSA Assay Improves Prostate Cancer Diagnosis

BOSTON—Researchers have reported findings from a study showing that a new way to measure serum PSA is more accurate than currently used assays in discriminating the presence or...

 ED Patients at Higher Risk of Hip Fracture

ED Patients at Higher Risk of Hip Fracture

Men with erectile dysfunction (ED) should receive a checkup of their bone health, Taiwanese researchers suggest. Noting common pathogenic processes at work in the bone and...

Urology Referrals for Elevated PSA Unchanged

Urology Referrals for Elevated PSA Unchanged

The 2012 United States Preventive Services Task Force (USPSTF) grade D recommendation against PSA screening has not affected the number of patients referred to urologists for a...

 Optimal PSA Threshold For Targeted Biopsy Identified

Optimal PSA Threshold For Targeted Biopsy Identified

The diagnostic usefulness of magnetic resonance imaging/ultrasound (MRI/US) fusion targeted prostate biopsy is optimized in patients with a PSA level of 5.2 ng/mL or higher,...

 Extraprostatic Extension Indicates Aggressive Prostate Cancer

Extraprostatic Extension Indicates Aggressive Prostate Cancer

Extraprostatic extension (EPE) detected on prostate needle biopsy is associated with adverse pathology at radical prostatectomy (RP), investigators confirm. Farzana A....

 Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes

Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes

Radical prostatectomy with adjuvant external beam radiotherapy (EBRT) or androgen deprivation therapy (ADT), or both, for biopsy Gleason score 9–10 prostate cancer offers...

Very High-Risk Prostate Cancer Criteria Validated as a Risk Stratum

Very High-Risk Prostate Cancer Criteria Validated as a Risk Stratum

Among men undergoing radical prostatectomy for high-risk prostate cancer (PCa), those with very high-risk (VHR) PCa were significantly more likely to have adverse pathologic...

Delayed Prostate Cancer Treatment May Up Relapse Risk

Delayed Prostate Cancer Treatment May Up Relapse Risk

Delaying primary treatment of prostate cancer (PCa) up to 6 months does not appear to adversely affect outcomes, but longer delays can increase the likelihood of biochemical...

ED Highly Prevalent in Men with Failed Hypospadias Repair

ED Highly Prevalent in Men with Failed Hypospadias Repair

ORLANDO—Erectile dysfunction (ED) is highly prevalent among men with prior failed hypospadias repair who present for urethroplasty, researchers reported at the American...

 Post-Brachytherapy PSA Bounce Linked to Sexual Activity

Post-Brachytherapy PSA Bounce Linked to Sexual Activity

ORLANDO—Younger sexually active men are more likely to experience PSA bounce after undergoing brachytherapy for localized prostate cancer (PCa), Japanese researchers reported at...

 PSA Nadir in ADT Recipients: The Lower, The Better

PSA Nadir in ADT Recipients: The Lower, The Better

Even an extremely low but still detectable PSA nadir in men receiving androgen-deprivation therapy (ADT) after radical prostatectomy for prostate cancer (PCa) strongly predicts...